Neurovascular Transduction During Exercise in Chronic Kidney Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.
Also called NCT02947750
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose supportive care
- Phase
- Phase 2
- Enrolled
- 150 participants
- Registry
-
NCT02947750
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT02947750. Randomized; single masking; primary purpose supportive care. Start 2016-10 (actual); primary completion 2027-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Neurovascular Transduction During Exercise in Chronic Kidney Disease
- Acronym
- NeurovEx
- Condition
- Renal Insufficiency, Chronic
- Intervention (Drug)
- 6R-BH4
- Intervention (Other)
- 6R-BH4 placebo
- Intervention (Dietary supplement)
- Folic acid
- Intervention (Other)
- Exercise training
- Intervention (Other)
- Stretching
- Intervention (Dietary supplement)
- Histidine and beta-alanine supplementation
- Intervention (Other)
- Histidine and beta-alanine placebo
- Lead sponsor
- Emory University
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct02947750- Content hash
b6ed6a056ba977c372a0617083011b99792102f8d1f8cedb38cded33fc913d80